37.17

1.59% -0.60

Zai Lab Limited Adr (ZLAB)

Overview News Price History Option Chain Financials Why ZLAB Down? Discussions Forecast

Zai Lab Limited Adr stock is traded at $37.17, with a volume of 635.73K. It is down -1.59% in the last 24 hours and up +0.57% over the past month. Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

Previous Close:

$37.77

Open:

$36.8

24h Volume:

635.73K

Relative Volume:

0.73

Market Cap:

$4.13B

Revenue:

$418.33M

Net Income/Loss:

$-252.07M

P/E Ratio:

-15.49

EPS:

-2.4

Net Cash Flow:

$-238.84M

1W Performance:

+10.72%

1M Performance:

+0.57%

6M Performance:

+41.49%

1Y Performance:

+96.98%

1-Day Range:

$36.51

$37.53

1-Week Range:

$34.54

$38.77

52-Week Range:

$16.01

$44.34

Zai Lab Limited Adr Stock (ZLAB) Company Profile

Name

Zai Lab Limited Adr

Sector

Healthcare (1164)

Industry

Biotechnology (651)

Phone

862161632588

Address

4560 JINKE ROAD, SHANGHAI

Employee

1,844

Twitter

Next Earnings Date

2024-11-12

Latest SEC Filings

ZLAB's Discussions on Twitter

Compare ZLAB with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ZLAB Zai Lab Limited Adr	37.17	4.17B	418.33M	-252.07M	-238.84M	-2.40
VRTX Vertex Pharmaceuticals Inc	469.65	121.28B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	563.10	60.96B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	328.81	42.77B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	591.99	36.21B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	291.47	32.08B	3.81B	-644.79M	-669.77M	-6.24

Zai Lab Limited Adr Stock (ZLAB) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-07-25	Initiated	Scotiabank	Sector Outperform
Mar-03-25	Downgrade	BofA Securities	Buy → Neutral
Dec-14-23	Initiated	Morgan Stanley	Overweight
Aug-10-23	Initiated	Cantor Fitzgerald	Overweight
Jan-21-22	Initiated	Macquarie	Outperform
Oct-12-21	Initiated	Bernstein	Mkt Perform
Apr-28-20	Initiated	Goldman	Buy
Apr-15-20	Initiated	Guggenheim	Buy
Jul-12-19	Initiated	BofA/Merrill	Buy
Jul-05-19	Initiated	Macquarie	Outperform
Jan-29-19	Initiated	Credit Suisse	Outperform
Nov-21-18	Initiated	Jefferies	Buy
Jun-21-18	Resumed	Leerink Partners	Outperform
Feb-14-18	Upgrade	JP Morgan	Neutral → Overweight
Oct-16-17	Initiated	JP Morgan	Neutral
Oct-16-17	Initiated	Leerink Partners	Outperform

View All

Zai Lab Limited Adr Stock (ZLAB) Latest News

03:34 AM

Cerity Partners LLC Makes New $420,000 Investment in Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) - Defense World

03:34 AM

Franklin FTSE Japan ETF (NYSEARCA:FLJP) Position Cut by Cerity Partners LLC - Defense World

03:34 AM

Cerity Partners LLC Takes Position in KANZHUN LIMITED Sponsored ADR (NASDAQ:BZ) - Defense World

03:34 AM

Cerity Partners LLC Purchases Shares of 19,622 Gold Fields Limited (NYSE:GFI) - Defense World

03:34 AM

03:32 AM

Envestnet Asset Management Inc. Raises Stock Position in First Trust Intermediate Government Opportunities ETF (NYSEARCA:MGOV) - Defense World

03:32 AM

Jul 25, 2025

Zai Lab Limited's (NASDAQ:ZLAB) large institutional owners must be happy as stock continues to impress, up 4.9% over the past week - simplywall.st

Jul 25, 2025

Jul 24, 2025

Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Shares Acquired by Envestnet Asset Management Inc. - Defense World

Jul 24, 2025

Knorr-Bremse (KNRRY) Expected to Announce Quarterly Earnings on Thursday - Defense World

Jul 24, 2025

Ero Copper (ERO) Expected to Announce Quarterly Earnings on Thursday - Defense World

Jul 24, 2025

Standard Chartered (SCBFY) Projected to Post Earnings on Thursday - Defense World

Jul 24, 2025

Jul 16, 2025

Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities - Benzinga

Jul 16, 2025

Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities16.07.25News - Ariva

Jul 16, 2025

Jul 15, 2025

M&T Bank Corp Reduces Stock Holdings in Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) - Defense World

Jul 15, 2025

Jul 10, 2025

Zai Lab to Announce Second Quarter 2025 Financial Results and Recent Corporate Updates on August 7, 2025 - Business Wire

Jul 10, 2025

Jul 03, 2025

Leerink Partnrs Issues Positive Outlook for Zai Lab Earnings - Defense World

Jul 03, 2025

Jun 30, 2025

Zai Lab Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor Receptor 2b (FGFR2b) Positive First-Line Gastric Cancer - Business Wire

Jun 30, 2025

Jun 26, 2025

Cantor Fitzgerald Expects Reduced Earnings for Zai Lab - Defense World

Jun 26, 2025

Jun 20, 2025

Zai Lab (ZLAB) Delivers Positive ZL-1503 Trial Results in Treatment of Atopic Dermatitis - Yahoo Finance

Jun 20, 2025

Jun 18, 2025

Metric Deep Dive: Understanding Winnebago Industries, Inc (WGO) Through its Ratios - DWinneX

Jun 18, 2025